Other OTC Pharmaceuticals - Oman

  • Oman
  • In 2024, the revenue generated by the Other OTC Pharmaceuticals market in Oman amounted to US$82.26m.
  • It is projected that this market will experience an annual growth rate of 1.39% (CAGR 2024-2029).
  • When compared globally, the in the United States leads in revenue generation, with US$7,171.00m in 2024.
  • On a per capita basis, the revenue generated in Oman amounts to US$17.45 per person in 2024.
  • The demand for OTC pharmaceuticals in Oman has been steadily increasing due to the country's growing population and rising healthcare awareness.

Key regions: Europe, Germany, United States, Brazil, Australia

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals market in Oman is experiencing steady growth due to various factors. Customer preferences in Oman are driving the demand for over-the-counter (OTC) pharmaceutical products. The market is also influenced by local special circumstances and underlying macroeconomic factors.Customer preferences in Oman play a significant role in the growth of the Other OTC Pharmaceuticals market. Omani consumers are increasingly seeking convenience and accessibility when it comes to healthcare products. They prefer to purchase OTC pharmaceuticals without the need for a prescription, as it saves time and allows them to address minor health issues independently. This preference for self-medication is driving the demand for OTC pharmaceutical products in Oman.Trends in the market indicate a shift towards natural and herbal remedies. Omani consumers are becoming more health-conscious and are seeking products that are perceived to be safer and more natural. This trend is driving the demand for OTC pharmaceuticals that contain natural ingredients and have fewer side effects. Manufacturers are responding to this trend by introducing a wide range of natural and herbal OTC pharmaceutical products in the market.Local special circumstances also contribute to the development of the Other OTC Pharmaceuticals market in Oman. The country has a high prevalence of lifestyle-related diseases such as diabetes and obesity. This has led to an increased demand for OTC pharmaceutical products that help manage these conditions. Additionally, the hot climate in Oman makes individuals more susceptible to certain health issues such as dehydration and heatstroke. OTC pharmaceutical products that address these specific needs are in high demand in the market.Underlying macroeconomic factors further support the growth of the Other OTC Pharmaceuticals market in Oman. The country has a stable economy with a growing middle class population. As disposable incomes increase, individuals have more purchasing power to spend on healthcare products, including OTC pharmaceuticals. The government of Oman also plays a role in promoting the availability and accessibility of OTC pharmaceuticals by ensuring a favorable regulatory environment.In conclusion, the Other OTC Pharmaceuticals market in Oman is developing due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Omani consumers' preference for convenience and accessibility, as well as the trend towards natural and herbal remedies, are driving the demand for OTC pharmaceutical products. Local special circumstances such as the prevalence of lifestyle-related diseases and the hot climate also contribute to market growth. Furthermore, the stable economy and favorable regulatory environment in Oman support the development of the Other OTC Pharmaceuticals market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)